Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA approves updated labeling for Lexiva

Nov. 25, 2005

First patient dosed in phase II study of VRX-496 for HIV

Nov. 25, 2005

Transgene and IAVI sign manufacturing agreement

Nov. 22, 2005

TMC-125 begins phase III program

Nov. 21, 2005

tgAAC-09 begins phase II study in South Africa

Nov. 17, 2005

Novel agents for HIV infection imparted in recent patent literature

Nov. 16, 2005

FDA approval for new Kaletra tablets formulation

Nov. 10, 2005

Savvy phase III HIV prevention trial in Ghana to be discontinued

Nov. 10, 2005

HIV protease inhibitors imparted in recent Sequoia patent

Nov. 4, 2005

Tibotec opens U.S. expanded access program for TMC-114

Nov. 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...